RWE and real-time insights

The COVID-19 pandemic triggered intense and widespread action among the biopharma industry and its regulators. From accelerating potential COVID-19 interventions to ascertaining healthcare’s redistribution, real-world evidence—delivered in real-time—helped inform questions on treatment impact and instruct commercial investment. This webinar, from the early days of the pandemic, demonstrates how real-world data (RWD) helped provide a longitudinal view of the nation's COVID journey and find a path forward.

In this webinar, you’ll learn:

How biopharma and regulators used RWD to answer questions on COVID-19 interventions and on the pandemic’s broader impact on healthcare
Considerations that were used for assessing data sources and tools for RWD-based research, as well as how Real-Time Insights and Evidence, a research system by Aetion and HealthVerity, enabled organizations to quickly respond and adapt
Examples of how real-time data sources were used to generate timely decision-ready insights across the drug lifecycle, including for regulatory and market access planning.